A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Phase of Trial: Phase III
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Alicaforsen (Primary)
- Indications Pouchitis
- Focus Registrational; Therapeutic Use
- Sponsors Atlantic Pharmaceuticals
- 08 Jan 2018 Planned End Date changed from 18 Jan 2018 to 30 Sep 2018.
- 08 Jan 2018 Planned primary completion date changed from 15 Sep 2017 to 31 Jul 2018.
- 12 Sep 2017 According to an Atlantic Healthcare media release, 110th patient has been recruited.